Jane Democratis
Overview
Explore the profile of Jane Democratis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
232
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li N, Njoku P, Mandal A, El Kafsi J, Hosack T, Stockdale T, et al.
Cureus
. 2025 Jan;
16(12):e75325.
PMID: 39776727
Introduction Surgical inpatients frequently require peripherally inserted central catheters (PICCs) for parenteral feeding and administration of medication. PICCs may cause upper limb deep venous thrombosis (ULDVT), which impacts patient morbidity....
2.
Baltas I, Gilchrist M, Koutoumanou E, Gibani M, Meiring J, Otu A, et al.
JAC Antimicrob Resist
. 2023 Aug;
5(4):dlad091.
PMID: 37533762
Objectives: A novel 'subscription-type' funding model was launched in England in July 2022 for ceftazidime/avibactam and cefiderocol. We explored the views of infection consultants on important aspects of the delinked...
3.
Baltas I, Stockdale T, Tausan M, Kashif A, Anwar J, Anvar J, et al.
J Glob Antimicrob Resist
. 2021 Apr;
25:187-192.
PMID: 33813029
Objectives: The long-term outcomes of patients following Gram-negative bacteraemia (GNB) are poorly understood. Here we describe a cohort of patients with GNB over a 2-year period and determine factors associated...
4.
Baltas I, Stockdale T, Tausan M, Kashif A, Anwar J, Anvar J, et al.
J Antimicrob Chemother
. 2020 Nov;
76(3):813-819.
PMID: 33219669
Objectives: There is limited evidence that empirical antimicrobials affect patient-oriented outcomes in Gram-negative bacteraemia. We aimed to establish the impact of effective antibiotics at four consecutive timepoints on 30 day...
5.
Toombs J, Van den Abbeele K, Democratis J, Mandal A, Missouris C
J Med Virol
. 2020 Jul;
93(1):177-179.
PMID: 32639585
No abstract available.
6.
Toombs J, Van den Abbeele K, Democratis J, Merricks R, Mandal A, Missouris C
J Med Virol
. 2020 Jun;
93(1):107-109.
PMID: 32542706
No abstract available.
7.
Dalton J, Shaw R, Democratis J
Lancet
. 2014 Mar;
383(9922):1098.
PMID: 24656202
No abstract available.
8.
Pimenta D, Democratis J
BMJ Case Rep
. 2013 Oct;
2013.
PMID: 24108774
A 49-year-old man with a history of hypertension and no known drug allergies was admitted with a 4-day history of fever, general malaise, sore throat and diarrhoea. Eleven days ago,...
9.
Stephenson I, Democratis J, Lackenby A, McNally T, Smith J, Pareek M, et al.
Clin Infect Dis
. 2009 Jan;
48(4):389-96.
PMID: 19133796
Background: Oseltamivir, a specific influenza neuraminidase inhibitor, is an effective treatment for seasonal influenza. Emergence of drug-resistant influenza viruses after treatment has been reported, particularly in children in Japan, where...
10.
Lackenby A, Thompson C, Democratis J
Curr Opin Infect Dis
. 2008 Nov;
21(6):626-38.
PMID: 18978531
Purpose Of Review: Neuraminidase inhibitor resistant influenza virus has recently emerged, and circulated, in untreated persons. Influenza virus evolution is causing antiviral susceptibility to change. We review the latest research...